164 related articles for article (PubMed ID: 31401556)
1.
Papa V; Rama P; Radford C; Minassian DC; Dart JKG
Br J Ophthalmol; 2020 Apr; 104(4):575-581. PubMed ID: 31401556
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis.
Carnt N; Robaei D; Watson SL; Minassian DC; Dart JK
Ophthalmology; 2016 May; 123(5):984-90. PubMed ID: 26952591
[TBL] [Abstract][Full Text] [Related]
3. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
Lim N; Goh D; Bunce C; Xing W; Fraenkel G; Poole TR; Ficker L
Am J Ophthalmol; 2008 Jan; 145(1):130-5. PubMed ID: 17996208
[TBL] [Abstract][Full Text] [Related]
4. The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1.
Dart JKG; Papa V; Rama P; Knutsson KA; Ahmad S; Hau S; Sanchez S; Franch A; Birattari F; Leon P; Fasolo A; Kominek EM; Jadczyk-Sorek K; Carley F; Hossain P; Minassian DC
Ophthalmology; 2024 Mar; 131(3):277-287. PubMed ID: 37802392
[TBL] [Abstract][Full Text] [Related]
5. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
Robaei D; Carnt N; Minassian DC; Dart JK
Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
Tu EY; Joslin CE; Sugar J; Shoff ME; Booton GC
Ophthalmology; 2008 Nov; 115(11):1998-2003. PubMed ID: 18571729
[TBL] [Abstract][Full Text] [Related]
7. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.
Duguid IG; Dart JK; Morlet N; Allan BD; Matheson M; Ficker L; Tuft S
Ophthalmology; 1997 Oct; 104(10):1587-92. PubMed ID: 9331195
[TBL] [Abstract][Full Text] [Related]
8. Successful medical treatment of Acanthamoeba keratitis.
Azuara-Blanco A; Sadiq AS; Hussain M; Lloyd JH; Dua HS
Int Ophthalmol; 1997-1998; 21(4):223-7. PubMed ID: 9700010
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acanthamoeba keratitis with intravenous pentamidine before therapeutic keratoplasty.
Sacher BA; Wagoner MD; Goins KM; Sutphin JE; Greiner MA; Kitzmann AS
Cornea; 2015 Jan; 34(1):49-53. PubMed ID: 25255139
[TBL] [Abstract][Full Text] [Related]
10. Analysis from a year of increased cases of Acanthamoeba Keratitis in a large teaching hospital in the UK.
Hassan F; Bhatti A; Desai R; Barua A
Cont Lens Anterior Eye; 2019 Oct; 42(5):506-511. PubMed ID: 31018907
[TBL] [Abstract][Full Text] [Related]
11.
Carnt N; Robaei D; Minassian DC; Dart JKG
Br J Ophthalmol; 2018 Oct; 102(10):1431-1435. PubMed ID: 29298778
[TBL] [Abstract][Full Text] [Related]
12. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis.
Bouheraoua N; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie VM
Cornea; 2013 Feb; 32(2):130-6. PubMed ID: 23132441
[TBL] [Abstract][Full Text] [Related]
14. Acanthamoeba Keratitis: Perspectives for Patients.
Bonini S; Di Zazzo A; Varacalli G; Coassin M
Curr Eye Res; 2021 Jun; 46(6):771-776. PubMed ID: 33151784
[No Abstract] [Full Text] [Related]
15. [Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].
Donoso R; Mura JJ; López M
Rev Med Chil; 2002 Apr; 130(4):396-401. PubMed ID: 12090104
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Acanthamoeba keratitis.
Lindquist TD
Cornea; 1998 Jan; 17(1):11-6. PubMed ID: 9436874
[TBL] [Abstract][Full Text] [Related]
17. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.
Khan YA; Kashiwabuchi RT; Martins SA; Castro-Combs JM; Kalyani S; Stanley P; Flikier D; Behrens A
Ophthalmology; 2011 Feb; 118(2):324-31. PubMed ID: 20884060
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.
Carrijo-Carvalho LC; Sant'ana VP; Foronda AS; de Freitas D; de Souza Carvalho FR
Surv Ophthalmol; 2017; 62(2):203-218. PubMed ID: 27836717
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
Larkin DF; Kilvington S; Dart JK
Ophthalmology; 1992 Feb; 99(2):185-91. PubMed ID: 1553206
[TBL] [Abstract][Full Text] [Related]
20. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
